Dose escalation of cabozantinib as a viable option for the treatment of mRCC. This is an ASCO Meeting Abstract from the 2018 Genitourinary Cancers Symposium. This abstract does not include a full text ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results